ストックスクリーナーアプリを入手
1.47
3.92%
-0.06
アフターアワーズ：
1.51
0.04
+2.72%
前日終値:
$1.53
開ける：
$1.54
24時間の取引高:
462.13K
Relative Volume:
0.49
時価総額：
$48.63M
収益：
$3.04M
当期純損益:
$-33.97M
株価収益率:
-1.1053
EPS:
-1.33
ネットキャッシュフロー:
$-52.47M
1週間 パフォーマンス:
-3.29%
1か月 パフォーマンス:
+8.09%
6か月 パフォーマンス:
-50.34%
1年 パフォーマンス:
-60.16%
1日の値動き範囲:
$1.4101
$1.54
1週間の範囲:
$1.4101
$1.58
52週間の値動き範囲:
$1.24
$8.75
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
名前
Rani Therapeutics Holdings Inc
セクター
電話
(408) 457-3700
住所
2051 RINGWOOD AVENUE, SAN JOSE
RANI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
1.47 | 48.63M | 3.04M | -33.97M | -52.47M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-02 | 開始されました | Oppenheimer | Outperform |
| 2024-06-14 | 開始されました | Maxim Group | Buy |
| 2024-06-13 | 開始されました | Rodman & Renshaw | Buy |
| 2023-04-17 | 再開されました | BTIG Research | Buy |
| 2022-10-11 | 開始されました | UBS | Buy |
| 2022-07-27 | 開始されました | H.C. Wainwright | Buy |
| 2022-06-13 | 開始されました | Wedbush | Outperform |
すべてを表示
Rani Therapeutics Holdings Inc (RANI) 最新ニュース
Rani Therapeutics’ (RANI) Buy Rating Reiterated at Canaccord Genuity Group - Defense World
Canaccord Genuity Group Reiterates Buy Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat
Power to the People: How Individual Investors Shape Rani Therapeutics - Smartphone Magazine
Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$11m last week - Yahoo Finance
RANI Shares Experience Surge in Value - Knox Daily
Janney Montgomery Scott LLC Buys New Position in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) - Defense World
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Rani Therapeutics (NASDAQ:RANI) Given Buy Rating at HC Wainwright - MarketBeat
Analysts Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $12.33 - Defense World
Analyzing PSQ Holdings Inc (PSQH) After Recent Trading Activity - Knox Daily
Rani Therapeutics’ (RANI) Buy Rating Reiterated at HC Wainwright - Defense World
These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week - Asianet Newsable
Rani Therapeutics (NASDAQ:RANI) Shares Up 0.7%Time to Buy? - MarketBeat
Rani Therapeutics (NASDAQ:RANI) Receives “Buy” Rating from HC Wainwright - Armenian Reporter
Was there any good news for Rani Therapeutics Holdings Inc (RANI) stock in the last session? - US Post News
Is Rani Therapeutics Holdings (NASDAQ:RANI) Using Too Much Debt? - Simply Wall St
Market cap of Tantech Holdings Ltd [TANH] reaches 1.11M – now what? - The DBT News
Rani Therapeutics Holdings Inc (RANI Stock: A Sea of Opportunity - The InvestChronicle
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Rani Therapeutics Discloses Progress in Oral Obesity Treatment; Shares Surge Premarket - Marketscreener.com
12 Health Care Stocks Moving In Thursday's Pre-Market SessionInvivyd (NASDAQ:IVVD), (AVGR) - Benzinga
Rani Therapeutics reports positive obesity treatment study - MSN
Rani Therapeutics reports positive obesity treatment study By Investing.com - Investing.com South Africa
Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery Of Semaglutide Via Ranipill HC - Marketscreener.com
Rani Therapeutics Announces Preclinical Data Demonstrating - GlobeNewswire
Oral Wegovy Alternative Shows Breakthrough Results: Rani's Pill Matches Injectable Efficacy - StockTitan
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
A company insider recently sold 72,842 shares of Luminar Technologies Inc [LAZR]. Should You Sale? - Knox Daily
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Consensus PT from Brokerages - MarketBeat
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Consensus Target Price from Analysts - Defense World
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Average Target Price from Brokerages - MarketBeat
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Shares Purchased by Geode Capital Management LLC - Defense World
Rani Therapeutics stock hits 52-week low at $1.29 - Investing.com India
Rani Therapeutics stock hits 52-week low at $1.29 By Investing.com - Investing.com South Africa
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Shares Acquired by Stifel Financial Corp - Defense World
Analysts Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $11.71 - Defense World
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Average PT from Brokerages - MarketBeat
Rani Therapeutics stock hits 52-week low at $1.32 - Investing.com
Insider Buying: Kate Mckinley Acquires Shares in Rani Therapeuti - GuruFocus.com
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Insider Kate Mckinley Acquires 17,960 Shares - MarketBeat
Rani Therapeutics stock hits 52-week low at $1.85 By Investing.com - Investing.com Nigeria
Rani Therapeutics stock hits 52-week low at $1.85 - Investing.com India
CEO Talat Imran Acquires Additional Shares of Rani Therapeutics Holdings Inc (RANI) - GuruFocus.com
Rani Therapeutics stock hits 52-week low at $1.94 By Investing.com - Investing.com Nigeria
Rani Therapeutics Holdings Inc (RANI) 財務データ
収益
当期純利益
現金流量
EPS
Rani Therapeutics Holdings Inc (RANI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Imran Talat | Chief Executive Officer |
Dec 09 '24 |
Buy |
1.94 |
10,296 |
19,974 |
494,751 |
| South Cone Investments Limited | 10% Owner |
Oct 15 '24 |
Sale |
2.65 |
3,829,360 |
10,141,674 |
8,302,194 |
6.45%
1.23%
大文字化:
|
ボリューム (24 時間):